Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Abbott 

Alinity ci-series

Company

Abbott 

Name of instrument

Alinity ci-series

Contact

US Marketing Core Diagnostics

Email

ats@abbott.com

City, State

Abbott Park, IL

Phone

800-323-9100  

Website

https://www.corelaboratory.abbott

Type of instrument

combination chemistry/immunoassay

Operational type/Model type

batch, random access, continuous random access, discrete/floor standing

List price/First year sold in U.S.

—/2018

Targeted hospital bed size/Targeted test volume

all/—

Company manufactures instrument

yes 

Other models in this family of analyzers

No. of units in clinical use in U.S./Outside U.S. (countries)

~2, 875/~14, 750 (154 countries)

Dimensions (H × W × D)/Instrument footprint

4.4 x 3.9 x 3.84 for standalone module; up to 4.4 x 11.81 x 3.84 for 4-module system/14.98–45.31 sq. ft. for 1- to 4-module system

Weight empty/Weight fully loaded

chem: 1, 556 lbs.; immuno: 1, 371 lbs./—

No. of different measured assays onboard simultaneously

chem: up to 280 (up to 280 can be run and calibrated at one time); immuno: up to 188 (up to 188 can be run and calibrated at one time)

No. of user-definable (open chemistry) channels

10 (10 can be active simultaneously)

Test throughput per hour/Assay run time

up to 5, 400 for Alinity c 4-module system; up to 800 for Alinity i 4-module system/depends on configuration

No. of direct ion-selective electrode channels

3

Detection methods

photometry, potentiometry

• Ion-selective electrode

• Basic metabolic panel

• Complete metabolic panel

Typical time delay from ordering stat test until aspiration of sample

< 30 sec.

Fully automated microplate immunoassay system

no

Methodologies supported

chemiluminescence

Separation methodologies

magnetic particle

Stat time until completion of a ß-hCG test

Stat time until completion of a cTn test

• Typical time delay from test order to aspiration of sample

Approximate No. of tests per reagent set/Reagent type

up to 1, 500 (chem), up to 600 (immuno)/self-contained multiuse

Reagents refrigerated onboard/Reagents ready to use

yes (2x–10xC [chemistry], 2°–12°C [immunoassay])/yes

Reagent lot tracking/Reagent inventory

yes/yes

Reagent form/Reagents barcoded

liquid chemistry (open reagent system)/yes

Separate reagent pack for each specimen/for each test run

no/no

Walkaway capability/Walkaway duration

yes/240 min. or up to 600 specimens (150 specimens per module)

Design of sample-handling system

6-position rack

Uses washable cuvettes/Uses disposable cuvettes

chem: yes/immuno: yes (can store up to 1, 000 cuvettes)

Min.–max. sample volume that can be aspirated at one time 

1.5–35 µL (chemistry), 2–200 µL (immunoassay)

Min. reaction volume/Min. specimen volume/Min. dead volume

80 µL/assay dependent/50 µL

Dedicated pediatric sample cup

no

Primary tube sampling

yes

Accommodates most standard tube sizes/Accepts nonstandard tube sizes

yes/yes (10–16.1 x 72–102 mm)

Pierces caps on primary tubes

no

Protects against probe collision

yes

Detects clots/liquid level/short sample

yes/yes/yes

Detection or quantitation for hemolysis, icterus, lipemia, clots

detection for hemolysis, icterus, lipemia, clots; quantitation for hemolysis, icterus, lipemia

Dilutes patient samples onboard/Susceptibility to carryover

yes/0.1 parts per million

Sample volume can be diluted to rerun out-of-linear-range high results

yes

Sample volume can be concentrated to rerun out-of-linear-range low results

Analyzer requires dedicated water supply

yes (27 L/hr. consumption during operation for chemistry, <10 L/hr. for immunoassay)

Autocalibration/Multipoint calibration supported

yes (calibrants are stored onboard)/yes 

Typical calibration frequency for ISE/therapeutic drugs/drugs of abuse/general chemistries/immunoassays

1 day/new lot or 7–45 days/new lot or 13 days/new lot or 30 days/new lot or 30 days

Automatic programmable start/Automatic programmable shutdown

—/no

Supports multiple QC lot numbers per analyte

yes

Waste management

automated collection onboard instrument or direct to drain

Sample barcode-reading capability/Autodiscrimination

yes (Interleaved 2 of 5, Codabar, Code 39, Code 128)/yes

Lab can control analyzer from remote computer

yes

Instrument can diagnose its own malfunctions

yes (operator intervention required to order parts)

System malfunctions can be diagnosed via remote monitoring

yes

UPS backup power supply

yes

Data-management capability/LIS or EHR systems interfaced

onboard/—

LIS interface provided/Bidirectional interface capability

no/yes (broadcast download and host query)

Modem servicing provided/Service engineer on-site response time

—/based on contract

Mean time between failures

— (displays error codes for troubleshooting)

Average scheduled maintenance time by lab personnel

daily: 0 (chem and immuno); weekly: 30 min. (chem), 16 min. (immuno); monthly: 2 min. (chem), 0 (immuno)

Maintenance records kept onboard for user/vendor

some records (includes audit trail of who replaced parts)/no

Maintenance training demonstration module onboard

yes

Training included with purchase/Avg. time for basic user training

yes (2 training slots)/12 hrs. (at customer site)

Advanced operator training/Extra charge for follow-up or advanced training

yes (at customer or vendor site)/yes

Warranty provided/Cost of annual service contract (24 h/7 d)

yes (varies by contract)/varies by contract

Distinguishing features (supplied by company)

compact, flexible, and scalable up to four modules and 14 configurations; harmonized family of systems across key lab disciplines leading to easier cross-training for lab staff; broad menu of high-quality assays aligned to CLSI guidelines

More products
in this guide

ASI Evolution RPR Syphilis Analyzer
DxI 9000 Access Immunoassay Analyzer
Pictus 700 (P700)
Agility Automated ELISA System
Envoy 500/Envoy 500+ Chemistry Analyzer
AIX1000 Agglutination Instrument
Yumizen C560
VITROS 4600 Chemistry System
VITROS XT 7600 Integrated System
cobas 8000 modular analyzer series
cobas pro integrated solutions
dIFine P30 Processor
IMMULITE 2000 XPi Immunoassay System
Phadia 250 Laboratory System
QUANTA-Lyser 3000